chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient admitted to hospital for hyperbilirubinemia and gallbladder sludge, had laparoscopic cholecystectomy on 12/14/2021. Patient presented to the ED and was subsequently hospitalized for pleural effusion and acute kidney injury. These visits are within 6 weeks of receiving covid vaccination.
Mother noticed arm red, swollen, and warm to the touch yesterday. Called MD. Has been given pt Benadryl, Tylenol, and ice pack to site.
sensitive to medication; CHILLS; muscle pain; sick with a bad cold; sick with a bad cold; cough that went down to my chest, still had a cough and tickling in my throat, never completely recovered; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick with a bad cold), NASOPHARYNGITIS (sick with a bad cold), COUGH (cough that went down to my chest, still had a cough and tickling in my throat, never completely recovered), SENSITISATION (sensitive to medication) and CHILLS (CHILLS) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced ILLNESS (sick with a bad cold), NASOPHARYNGITIS (sick with a bad cold) and COUGH (cough that went down to my chest, still had a cough and tickling in my throat, never completely recovered). On an unknown date, the patient experienced SENSITISATION (sensitive to medication), CHILLS (CHILLS) and MYALGIA (muscle pain). At the time of the report, ILLNESS (sick with a bad cold), NASOPHARYNGITIS (sick with a bad cold), COUGH (cough that went down to my chest, still had a cough and tickling in my throat, never completely recovered), SENSITISATION (sensitive to medication), CHILLS (CHILLS) and MYALGIA (muscle pain) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: Inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.   This case was linked to MOD-2021-052120 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Patient route of administration was updated as unknown
Swelling, redness 12-15 cm circular area. Next day after immunizations, Painful red. Seen 5 days later, redness diminished  Instr. Benadryl for comfort
PATIENT CALLED US 3 DAYS AFTER RECEIVING VACCINE AND SAID FAINTING, FEVER--PATIENT CALLED HER FAMILY DOCTOR AND PER PATIENT THE DOCTOR STATED THAT THE FAINTING, FEVER WAS FROM ILLNESS NOT VACCINE.
Cold sensation down arm below elbow to hand (by thumb).; Burning sensation down arm below elbow to hand (by thumb); This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient did not have any known allergies to medications, food or other products. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 11:15, the patient experienced cold and burning sensation down arm below elbow to hand (by thumb). The patient reported that this occurred on and off for about 20-30 minutes after and was first felt 20 minutes after the injection. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event cold and burning sensation down arm below elbow to hand (by thumb). The clinical outcomes of the events cold and burning sensation down arm below elbow to hand (by thumb) was resolved on 08Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Following my fourth rabies booster shot, I developed a large red lump in the same arm later that day.  It was sore, but did not itch.  It was further down the arm than the shot that was administered.  After a couple days, the swelling and redness decreased, but two weeks later I still have a small lump under the skin.  This is also the same arm that I was bitten.
Information has been received from a health professional concerning a 5 year old male with no past medical history and no known drug allergies who on 3/16/00 was vaccinated in the thigh with a first dose of varicella virus vaccine live. There was no illness at the time of vaccination. On 9/9/04, the patient broke out with shingles. A doctor's visit was required. There were no relevant diagnostic tests or laboratory data. Follow up information indicated that the outcome was reported as recovered. No additional information is expected.
PRESENTED WITH ACUTE ONSET LEFT EYE BLURRED VISION AND VISION LOSS.  CONCERN FOR CENTRAL RETINAL ARTERY OCCLUSION. RECEIVED TNK. SYMPTOMS IMPROVED AFTER TNK ADMINISTRATION.
Day 10 - I have a profound red raised patch where the vaccine was administered. I have pics if needed of the site. The site is about the size of a goof ball.
admitted to hospital  due to left lower extremity pulselessness, patient reports intermittent pain/pallor since 5/4 which worsened to point of being unable to move her leg
After receiving vaccine patient became unresponsive and had ?posturing like behavior.  After a minute or two patient responded to strong sternal rub and was transported to ER for further evaluation.
Pt came to clinic on 1/23/18 and reported that she has had pain at injection site since administration on 11/1/17. Pt had had surgeries on wrist on same arm, possible nerve inflammation/irritation triggered higher up in upper arm after flu shot injection. Provider advised pt to schedule an apt for evaluation with her PCP to assess arm.
heart pain; bone pain; muscle pain; heart palpitations; headache; joint pain lasting 3 weeks; severe dizziness; severe stomach pain; chest tightness 1 week; cough 1 week; exhaustion 1 week; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE), dose 2 at vaccination age of 34-year-old via an unspecified route of administration in the left arm on 24Apr2021 11:00 (Lot Number: ew0169) as 2nd dose, single for covid-19 immunisation. Medical history included JME (juvenile myoclonic epilepsy). The patient received the first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE) at vaccination age of 34-year-old on 03Apr2021 11:00 AM (lot number: ew0150) in the left arm for COVID-19 Immunisation. Concomitant medications included divalproex sodium (reported as Divalproex Sodium ER) taken for an unspecified indication, start and stop date were not reported. The patient previously took phenobarbital but experienced allergies. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the most recent COVID-19 vaccine in a doctor's office/urgent care. On 24Apr2021 04:00 PM, the patient experienced bone pain, muscle pain, headache, heart palpitations, heart pain, joint pain lasting 3 weeks (May2021), severe dizziness, severe stomach pain, chest tightness 1 week (May2021), cough 1 week (May2021) and exhaustion 1 week (May2021). The adverse events resulted in an emergency room/department or urgent care and the patient received treatment for the adverse events which included medicine for stomach pain, instructions to wait. The patient has not been tested for Covid-19 since the vaccination. The outcome of the events chest tightness, cough, exhaustion and joint pain were recovered in May2021 with sequelae while the outcome of the other events was recovered on an unspecified date in 2021 with sequelae.
Patient has no symptoms to the vaccine given.  Parent was advised to advise our office if any symptoms occur so she can be evaluated.
LEFT DELTOID AREA OF INJECTION SHOWED SWELLING, REDNESS, WARM AND PAIN. ADVISED WARM PACKS, IBUPROFEN/TYLENOL, BENADRYL CREAM OR ORALS. F/U IF NO IMPROVEMENT.
Moderna vaccine booster was administered on 11/5/2021 with an expiration date of 10/11/2021. Inquiry has been submitted to Moderna requesting validation of vaccine potency.  A response from Moderna is expected to be received between 8-10 business days.  Expiration date is currently not printed on the vaccine vial or carton and vaccine expiration date listed in database is 12/31/2069.  To find the expiration date, ?look up expiration date? tool is to be used from Vial Expiration Date Lookup | Moderna COVID-19 Vaccine (EUA). Patient contacted on 12/4/2021 and no adverse effects reported.
Fussy, congestion, rash (prominent 3-5mm maculopapular rash that are erythematous and blanching with 'stuck-on' appearance over face and trunk. No involvement of palms/soles).
don't really know how I felt right afterwards; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 03-Dec-2020.  This case involves a patient of unknown demographics who didn't really know how he/she felt right afterwards (feeling abnormal), while the patient received vaccine Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was unknown.  On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, unspecified time after receiving the vaccine, the patient reported that he/she had other concerns after he/she got it, so the patient didn't really know how he/she felt right afterwards (feeling abnormal).   It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.      The reporter assessed the causal relationship with suspect vaccine as related.
Pt developed urticaria (hives) 1-2 hours after receiving his 5th dose of rabies vaccine on 9/21/04. History of bats exposure. Treated with Benadryl 50 mg po. Hives cleared in 1-2 hours. No other problems the lot no was the same as the previous 4 injections, a sibling received 5 doses of the same lot number without any reaction.
didn't feel well; dizziness; fast heartbeat; fever, temperature was 101.6; headache; body aches; joint pain; chills; her left arm was really sore at the injection site; A spontaneous report was received from a consumer concerning a female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced not feeling well/malaise, dizziness, fever temperature was 101.6/pyrexia, headache, body aches/pain, joint pains/arthralgia, chills, fast heartbeat/heart rate increased and left arm sore at injection site/injection site pain.  The patient's medical history was not provided. No concomitant medications were reported.  On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot#) intramuscularly for prophylaxis of COVID-19 infection.  On 29 Dec 2020, the patient didn't feel well, had dizziness, had a fever of 101.6 degrees Fahrenheit, headache, body aches, joint pains, chills, fast heartbeat and her left arm was sore at injection site.  Treatment information included Tylenol, Benadryl and Nyquil.   The Action taken with mRNA-1273 in response to the events was unknown.  The outcome for the events, didn't feel well, dizziness, headache, body aches, joint pains, chills, fast heartbeat and left arm sore at injection site was considered unknown.  The outcome for the event, fever temperature was 101.6 considered recovered/resolved on 30 Dec 2020.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This case was reported by a other health professional via call center representative and described the occurrence of pain in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced pain, swelling and erythema. On an unknown date, the outcome of the pain, swelling and erythema were unknown. It was unknown if the reporter considered the pain, swelling and erythema to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The health care professional had no vaccine or patient information except patient's gender. The patient experienced pain, redness and swelling after receiving a dose of SHINGRIX.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 16-NOV-2018, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number N034400 with expiration date in 10-MAY-2019) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011434: US-009507513-1907USA001849: US-009507513-1907USA001847: US-009507513-1907USA001848: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA000952: US-009507513-1907USA000953: US-009507513-1907USA000954: US-009507513-1907USA000959: US-009507513-1907USA000962: US-009507513-1907USA000963: US-009507513-1907USA000964: US-009507513-1907USA000965: US-009507513-1907USA000966: US-009507513-1907USA000967: US-009507513-1907USA000968: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000988: US-009507513-1907USA000989:
This case was reported by a healthcare professional and described the occurrence of injection site redness in a 19-month-old male subject who was vaccinated with KINRIX (GlaxoSmithKline). Previous and/or concurrent vaccination included HIBERIX (GlaxoSmithKline); unknown; unknown given on 28 September 2010; PREVNAR (non-gsk); Wyeth Labs; unknown; unknown given on 28 September 2010; FLUZONE (non-gsk); Sanofi Pasteur MSD; unknown; unknown given on 28 September 2010. On the morning of 28 September 2010 the subject received 1st dose of KINRIX (details unknown), and experienced wrong vaccine administered. The subject was younger than the recommended age for administration of KINRIX. On 28 September 2010 in the evening, less than one day after vaccination with KINRIX, the subject experienced injection site redness. At the time of reporting the event was resolved. The healthcare professional considered the event was probably related to vaccination with KINRIX.
This spontaneous report was received from a nurse concerning a 23 year old female patient. On 07-FEB-2015 the patient was vaccinated in error with a pediatric dose of VAQTA 25/0.5 (units not provided) (lot # and route were not provided). no adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Patient was doing paperwork when he experienced the worst headache of his life on 4/17 with associated emesis. Patient found to have a Hunt Hess 3 Fisher Grade 3 Subarachnoid Hemorrhage with hydrocephalus s/p EVD,  s/p cerebral angiogram on 4/18 negative for aneurysm/AVM. On the evening of 4/20, patient became acutely hypoxic with wheezing for which he required oxygen via 10L oxymask. During 4/21, his oxygen requirements continued to increase with increased work of breathing requiring high flow nasal cannula (HFNC) at 50L/60%  + pulmonary congestion on imaging and he was treated with diuresis. On 4/22, oxygen needs increased requiring 70L/100% with worsening imaging. He was then started on steroids, antibiotics were broadened, epoprostenal started in addition to diuresis. On 4/23, patient reports improved breathing and is on non-rebreather. Antibiotics, steroids, and epoprostenal were discontinued as patient showed improvement of oxygenation without clear signs of infection. Of note,  patient reports vaping in the past 2-3 months.  Patient has also been intermittently febrile. Wife was concerned that these symptoms were possibly related to him getting the J&J vaccine on 4/11. Patient is currently still in hospital on day 6 of admission at this time.
approx 30 hrs p/recvd 2nd dose of Hep B vax pt exp rash limited to rt side of trunk; areas were focal/not general; hives appeared on 10AUG92; 11AUG92 blurred vision; mod to severe urticara on rt side of trunk also 30 hrs p/2nd dose;
Received vaccinations for immigration process.  Noted Lt arm evening of 6/11/08 to becoming swollen and itching.  Swelling has continued & become more so.  Rt arm sl. swollen with sl. redness.  Parts of circle are indurated.
9/15/17 approx. 3:30 PM, began sweating and chilling intermittently with nausea and extreme fatigue. The symptoms persisted until 9/17/17 afternoon, with one episode of vomiting on 9/16/17.  Symptoms gradually declined over the course of the weekend.
The next morning after my vaccination I was extremely dizzy and nauseous when I tried to get out of bed.  This lasted about four  hours. Then I could begin to slowly get up out of bed and walk around.   Twelve hours later I was almost back to normal, if I didn't move my head too fast. At 8:00 am  I called my doctor's office and talked with a nurse who was very helpful.   I slept 3 hours in the afternoon.   The next morning all the reaction was gone and I went about my normal activities.
102 fever, chills, muscle aches, sinus pressure, headache, pressure behind eyes. Eye irritation. Eye grittiness and pain. Trouble focusing the eyes. Sensitivity to light. Sudden onset of many black floaters in field of vision. Visual disruption. Dizziness.  Spontaneous vitreous degeneration.
Onset of pain at injection site of right arm followed by redness and fever and problems for 1 to 2 weeks.
allergic reaction, included any and all of its sequelae; allergic reaction, included any and all of its sequelae/ as well as other severe and personal injuries; This initial spontaneous report was received from a lawyer regarding a case in litigation, referring to a 64-year-old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 14-NOV-2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for prophylaxis (strength, dose, route of administration, anatomical location, lot number, and expiration date were not reported). On 17-NOV-2011, as a result of zoster vaccine live (ZOSTAVAX) administration, , foregoing act and omissions, the patient was caused to suffered serious and dangerous side effects included: allergic reaction, included any and all of its sequelae; as well as other severe and personal injuries which are permanent and lasting in nature, physical pain and mental anguish, included diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications. As a result of vaccine, the patient had been caused to suffered severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. It was reported that defects in zoster vaccine live (ZOSTAVAX) were substantial in caused patient's injuries. As a result of the foregoing acts and omissions the patient required and/or would require more health care and services and did incur medical, health, he would in the future be required to obtain further medical and/or hospital care, attention, and services. In addition, the patient required and would continue to require healthcare and services. The patient had incurred and would continue to incur medical and related expenses. Also had suffered and would continue to suffer diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravated of preexisted conditions, activation of latent conditions, and other losses and damages. The patient's direct medical losses and costs included physical care, monitoring and treatment. The patient had incurred and would continue to incur mental and physical pain and suffering. The outcome of hypersensitivity and ill-defined disorder were not recovered. The reporter considered of hypersensitivity and ill-defined disorder to be related to zoster vaccine live (ZOSTAVAX).  Hypersensitivity and ill-defined disorder were considered to be disable events.
Headache/ Tylenol (Treatment) back and forth, back and forth/ I get relief when I have it and then it come back again; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported, Expiration date was unknown), via an unspecified route of administration on an unknown date in Feb2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in Feb2021, the patient received COVID vaccine, given last week Monday. So, from then I have been having this headache. So, I have taken Tylenol (Treatment) back and forth, back and forth. Is like I get relief when I have it and then it come back again. The outcome of event was unknown.  Follow-up attempts are completed. No further information was expected.